Alexion Pharmaceuticals, Inc.

Pharmaceutical firm files resale registration statement for notes

Published in Healthcare Finance, Tax and Law Weekly, May 4th, 2005

Alexion Pharmaceuticals, Inc., (ALXN) announced that in connection with its January 2005 private placement of $150 million aggregate principal amount of 1.375% Convertible Senior Notes due 2012, it has filed a registration statement on Form S-3 with the U.S. Securities and Exchange Commission (SEC).

The registration statement was filed in satisfaction of certain registration rights obligations.

When declared effective by the SEC, the registration statement will be available for use by the selling security holders to publicly resell the 1.375% convertible senior Notes and the common shares of Alexion that can be issued upon conversion of the notes....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly

Source: Healthcare Finance, Tax and Law Weekly (2005-05-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry